Abivax (ABVX) Cash from Discontinued Operations (2025 - 2026)
Abivax (ABVX) recorded quarterly Cash from Discontinued Operations of 59144899.5 in Q1 2026, down 68.96% quarter-over-quarter from 35004610.38 in Q1 2025, and down 68.96% on a YoY basis from 190563599.23 in Q1 2025.
Abivax (ABVX) Cash from Discontinued Operations (2025 - 2026) Analysis & Trends
Abivax's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 59144899.5 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.14 Mn |
| Mar 31, 2026 | -59.14 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Mar 31, 2025 | -35.00 Mn |